City Therapeutics, Inc. is a biotechnology company specializing in next-generation RNA interference (RNAi) therapeutics. The company is based in Cambridge, MA. The company engineers potent, specific, and durable RNAi trigger molecules combined with precision targeting ligands to deliver siRNAs beyond the liver to tissues such as ocular and central nervous system targets. Its R&D pipeline includes programs addressing thromboembolic diseases (targeting Factor XI), Stargardt disease (targeting RBP4), and other hepatic, ocular, and CNS conditions. Lead candidates include CITY-FXI, designed to prevent blood clots with reduced bleeding risk, and CITY-RBP4, aimed at slowing or halting vision loss in Stargardt disease. The company was founded by Ari Nowacek, John M. Maraganore. Andrew C. Orth has been the CEO of the company since 2025.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of City Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. City Therapeutics Inc. market cap is $1.13B.
What is the 52-week high for City Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. City Therapeutics Inc. 52 week high is $23.88 as of October 18, 2026.
What is the 52-week low for City Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. City Therapeutics Inc. 52 week low is $18.00 as of October 18, 2026.
What is City Therapeutics Inc. stock price today?
City Therapeutics Inc. stock price today is $22.40.
What was City Therapeutics Inc. stock price yesterday?
City Therapeutics Inc. stock price yesterday was $18.00.
What is the 50-day moving average of City Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. City Therapeutics Inc. 50-day moving average is $20.20.